Long-Term Respiratory Muscle Endurance Training in Patients with Myasthenia Gravis: First Results after Four Months of Training

Table 2

Lung function data.


Patient	VC (L)			FEV₁ (L)			PEF (L s⁻¹)			MVV (L min⁻¹)			(kPa)
	B	P1	P4	B	P1	P4	B	P1	P4	B	P1	P4	B	P1	P4

1	3.8	4.1	4.2	3.1	3.3	3.9	7.1	6.2	7.6	142	150	133	9.1	9.4	9.5
2	3.9	3.8	4.0	3.1	3.1	3.1	8.6	8.0	8.4	138	131	188	9.5	10.9	11.4
3	3.1	3.4	3.3	2.3	2.6	2.4	4.5	5.1	4.7	74	73	84	5.6	6.9	7.0
4	3.7	3.7	3.6	2.9	3.2	2.9	7.6	9.4	9.0	130	152	144	8.9	8.9	8.3
5	3.7	3.4	3.5	2.8	2.5	2.5	7.7	7.8	8.9	124	121	114	4.3	5.3	5.3
6	3.9	3.6	4.4	2.7	2.6	3.5	4.7	5.3	7.2	73	89	105	6.6	5.8	6.3
7	2.8	2.7	2.6	2.1	2.1	2.0	4.9	5.1	4.4	91	91	97	5.6	6.6	5.1
8	4.6	4.7	4.4	3.1	2.9	2.9	7.0	7.4	7.4	162	154	155	8.1	9.0	9.3
9	2.6	2.6	2.8	2.1	2.4	2.3	4.6	4.4	5.1	76	75	81	5.9	5.1	4.6
10	2.7	2.9	3.5	1.9	2.2	2.5	7.1	7.6	7.5	94	92	90	5.9	5.8	6.1

Mean	3.5	3.5	3.6	2.6	2.7	2.8	6.4	6.6	7.0	110	113	119	6.7	7.1	7.1
SEM	0.20	0.20	0.20	0.15	0.13	0.18	0.49	0.52	0.53	10.3	10.3	11.1	0.57	0.67	0.75

VC; vital capacity; FEV₁; forced expiratory volume in 1 s; PEF; peak expiratory flow; MVV; maximal voluntary ventilation; ; maximal inspiratory pressure. B; baseline values; P1; posttraining test after 4 weeks of training (phase 1); P4; posttraining test after 4 months of training (phase 2).

Autoimmune Diseases

Long-Term Respiratory Muscle Endurance Training in Patients with Myasthenia Gravis: First Results after Four Months of Training

Table 2